Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xilio Therapeutics (XLO) Other Non-Current Assets (2024 - 2025)

Historic Other Non-Current Assets for Xilio Therapeutics (XLO) over the last 2 years, with Q3 2025 value amounting to $1.8 million.

  • Xilio Therapeutics' Other Non-Current Assets rose 146.48% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 146.48%. This contributed to the annual value of $1.8 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Xilio Therapeutics' Other Non-Current Assets is $1.8 million, which was up 146.48% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Xilio Therapeutics' Other Non-Current Assets ranged from a high of $2.8 million in Q1 2024 and a low of $1.8 million during Q2 2024